Aflibercept (AVE0005)
TCD11382
Phase 1 small_molecule completed
Quick answer
Aflibercept (AVE0005) for Neoplasm Malignant is a Phase 1 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Neoplasm Malignant
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed